NINGBOBENKANGJS PHARMTECHCO., LTD

Ningbo Benkang cornerstone Pharmaceutical Technology Co., Ltd. is mainly engaged in biotechnology, pharmaceutical technology research and development, technical consulting, technical services, technology transfer; sales of pharmaceutical intermediates and chemical products; import and export of self operated or agent goods and technologies. The company has built a drug molecular block library with various categories, novel structure and high performance for global pharmaceutical enterprises. Through the use and combination of these molecular blocks, new drug R & D enterprises can quickly obtain a large number of candidate compounds for screening and evaluation in the drug discovery stage, and efficiently discover the structure and activity relationship of compounds, and finally determine the clinical candidates. In order to meet customers' different needs for chemical synthesis in various stages of new drug development and provide more comprehensive and long-term stable quality services, the company has developed and strengthened the commercial production capacity of pharmaceutical molecular blocks and key intermediates while continuing to provide laboratory level molecular blocks. It can produce kilogram to ton molecular blocks, GMP and non GMP intermediates, The company has been adhering to the concept of "customer first, sharing and win-win", providing innovative and difficult synthetic technology products and services for global pharmaceutical and biotechnology companies. At present, the company's core business focuses on: ● molecular block ● process research and development Low molecular library compounds ● commercial reagents and APIs The company is committed to helping customers to save the cost of new drug development and shorten the time of new drug marketing, so as to contribute to the fight against diseases